John McEwan

586 total citations
10 papers, 479 citations indexed

About

John McEwan is a scholar working on Organic Chemistry, Molecular Biology and Toxicology. According to data from OpenAlex, John McEwan has authored 10 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Organic Chemistry, 4 papers in Molecular Biology and 4 papers in Toxicology. Recurrent topics in John McEwan's work include Bioactive Compounds and Antitumor Agents (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Folate and B Vitamins Research (3 papers). John McEwan is often cited by papers focused on Bioactive Compounds and Antitumor Agents (4 papers), Asymmetric Synthesis and Catalysis (3 papers) and Folate and B Vitamins Research (3 papers). John McEwan collaborates with scholars based in Australia, New Zealand and United States. John McEwan's co-authors include Gregory Russell‐Jones, Kirsten J. McTavish, David P. Nowotnik, John Rice, Margaret A. Brimble, Peter Turner and Richard Elliott and has published in prestigious journals such as Bioconjugate Chemistry, Journal of Inorganic Biochemistry and Tetrahedron Asymmetry.

In The Last Decade

John McEwan

10 papers receiving 467 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John McEwan Australia	8	213	151	123	103	71	10	479
Chenyue Zhan China	14	256 1.2×	81 0.5×	348 2.8×	117 1.1×	59 0.8×	17	614
Junwei Zhao China	12	160 0.8×	72 0.5×	68 0.6×	89 0.9×	21 0.3×	30	403
Geoffray Leriche United States	13	392 1.8×	239 1.6×	106 0.9×	90 0.9×	82 1.2×	28	612
Khaled El Cheikh France	14	343 1.6×	199 1.3×	287 2.3×	68 0.7×	39 0.5×	32	698
Witold M. Rybski United States	7	407 1.9×	326 2.2×	118 1.0×	43 0.4×	45 0.6×	7	604
Ming An United States	13	448 2.1×	44 0.3×	95 0.8×	107 1.0×	46 0.6×	25	601
Eric K. Lei Canada	8	437 2.1×	77 0.5×	179 1.5×	69 0.7×	35 0.5×	12	693
Shaina L. Carroll United States	8	366 1.7×	60 0.4×	123 1.0×	15 0.1×	38 0.5×	8	793
Ja-Yun Lim South Korea	7	112 0.5×	62 0.4×	156 1.3×	39 0.4×	23 0.3×	7	411
Wenyan Yao China	11	144 0.7×	60 0.4×	75 0.6×	23 0.2×	19 0.3×	30	457

Countries citing papers authored by John McEwan

Since Specialization

Citations

This map shows the geographic impact of John McEwan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John McEwan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John McEwan more than expected).

Fields of papers citing papers by John McEwan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John McEwan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John McEwan. The network helps show where John McEwan may publish in the future.

Co-authorship network of co-authors of John McEwan

This figure shows the co-authorship network connecting the top 25 collaborators of John McEwan. A scholar is included among the top collaborators of John McEwan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John McEwan. John McEwan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

1.

Russell‐Jones, Gregory, et al.. (2012). Increasing the Tumoricidal Activity of Daunomycin-pHPMA Conjugates Using Vitamin B12 as a Targeting Agent. 1(2). 203–211. 1 indexed citations

2.

Russell‐Jones, Gregory, Kirsten J. McTavish, & John McEwan. (2010). Preliminary studies on the selective accumulation of vitamin-targeted polymers within tumors. Journal of drug targeting. 19(2). 133–139. 27 indexed citations

3.

McEwan, John, et al.. (2009). Antibodies to Prion Protein Inhibit Human Colon Cancer Cell Growth. Tumor Biology. 30(3). 141–147. 19 indexed citations

4.

Russell‐Jones, Gregory, Kirsten J. McTavish, John McEwan, John Rice, & David P. Nowotnik. (2004). Vitamin-mediated targeting as a potential mechanism to increase drug uptake by tumours. Journal of Inorganic Biochemistry. 98(10). 1625–1633. 326 indexed citations

5.

Brimble, Margaret A., Richard Elliott, & John McEwan. (2000). Diels-Alder Addition of Acyclic Dienes to Chiral Naphthoquinones. Australian Journal of Chemistry. 53(7). 571–576. 14 indexed citations

6.

Brimble, Margaret A. & John McEwan. (2000). Enantioselective synthesis of a cyclopentannulated kalafungin analogue. ARKIVOC. 2000(6). 909–916. 2 indexed citations

7.

McEwan, John, et al.. (1999). Synthesis and Biological Activity of Ribose-5‘-Carbamate Derivatives of Vitamin B₁₂. Bioconjugate Chemistry. 10(6). 1131–1136. 43 indexed citations

8.

Brimble, Margaret A., John McEwan, & Peter Turner. (1998). Asymmetric Michael addition of 2-trimethylsilyloxyfuran to chiral naphthoquinones. Tetrahedron Asymmetry. 9(7). 1257–1267. 14 indexed citations

9.

Brimble, Margaret A., John McEwan, & Peter Turner. (1998). Asymmetric Diels–Alder addition of cyclopentadiene to chiral naphthoquinones. Tetrahedron Asymmetry. 9(7). 1239–1255. 13 indexed citations

10.

Brimble, Margaret A. & John McEwan. (1997). Use of bis(oxazoline)-metal complexes as chiral catalysts for asymmetric Diels-Alder reactions using 2-acetyl-1,4-naphthoquinone as a dienophile. Tetrahedron Asymmetry. 8(24). 4069–4078. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact